welcome
Investor's Business Daily

Investor's Business Daily

Health

Health

TG Therapeutics stock soars after beating Wall Street's fourth-quarter sales expectations

Investor's Business Daily
Summary
Nutrition label

70% Informative

TG Therapeutics stock rocketed 16.9% to 35.18 .

The biotech company handily beat Wall Street's fourth-quarter sales expectations and issued a bullish outlook for 2025 .

Sales soared roughly 250% year over year , TG said in a news release.

The company is well known for its multiple sclerosis treatment, Briumvi .